GoodRx keeps a running page on peptide regulation news, with a focus on what the FDA is doing about compounding pharmacies.
Recap by typeshit. Full story at GoodRx.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
Quartz reports on a large study suggesting weight loss drugs may reduce psychiatric hospital visits among people with schizophrenia.
Reuters reports on a growing field of developers racing into obesity drugs as competition gets tighter.
Loading…